Antibiotic News and Research

RSS
Century old drug clofazimine shows potential for multiple sclerosis

Century old drug clofazimine shows potential for multiple sclerosis

New insights into a avian pathogenic E. coli and its risks to human health

New insights into a avian pathogenic E. coli and its risks to human health

New bone cement may prevent amputations

New bone cement may prevent amputations

Helicobacter pylori can multiply in autophagic vesicles

Helicobacter pylori can multiply in autophagic vesicles

Eating fast food cancels out benefits of breastfeeding in preventing asthma

Eating fast food cancels out benefits of breastfeeding in preventing asthma

Sleeping with dogs!

Sleeping with dogs!

Study finds MRSA in swine and swine workers in the United States

Study finds MRSA in swine and swine workers in the United States

New formula accurately measures kidney function in children

New formula accurately measures kidney function in children

MRSA head and neck infections increase among children

MRSA head and neck infections increase among children

MRSA's weak point visualised by scientists

MRSA's weak point visualised by scientists

Gene technology to fight Clostridium difficile

Gene technology to fight Clostridium difficile

Discovery of potential new bactericide

Discovery of potential new bactericide

E. coli persists against antibiotics through HipA-induced dormancy

E. coli persists against antibiotics through HipA-induced dormancy

Thumbs down by experts on plans to make certain meds OTC

Thumbs down by experts on plans to make certain meds OTC

Tuberculosis commandeers body's defenses to gain foothold

Tuberculosis commandeers body's defenses to gain foothold

Discovery of better treatment for bacterial pneumonia

Discovery of better treatment for bacterial pneumonia

Discovery of novel ways to halt the spread of antibiotic resistance

Discovery of novel ways to halt the spread of antibiotic resistance

First artemisinin based malaria drug may meet resistance, expert says

First artemisinin based malaria drug may meet resistance, expert says

Sequella, Inc. drug compound SQ109 selected for phase 1B clinical trial program

Sequella, Inc. drug compound SQ109 selected for phase 1B clinical trial program

Discovery of new way for bacteria to transfer toxic genes to unrelated bacterial species

Discovery of new way for bacteria to transfer toxic genes to unrelated bacterial species

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.